Lewis J G
J Int Med Res. 1979;7(5):354-9. doi: 10.1177/030006057900700504.
An open trial was carried out on ten middle-aged and elderly patients in cardiac failure to assess the effect on plasma potassium levels of one or more tablets containing 40 mg frusemide and a controlled-release formulation containing 600 mg potassium chloride. Patients had previously been maintained on frusemide and potassium supplements given as separate tablets. No significant rise or fall was observed when treatment was changed to the combined tablet.
对10名心力衰竭的中老年患者进行了一项开放性试验,以评估含40毫克速尿的一片或多片片剂以及含600毫克氯化钾的控释制剂对血浆钾水平的影响。患者此前一直服用速尿和钾补充剂,二者为分开的片剂。当改为服用复方片剂时,未观察到显著的升高或降低。